Reported Jan 31, 2025 · Announced
Alvogen, Inc. recalls Alvogen Fentanyl Transdermal System 25 mcg/h transdermal patches due to There is potential that patches could be multi-stacked, adhered…
Alvogen, Inc.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Fentanyl Transdermal System 25
- mcg/h transdermal patches BrandAlvogen. Drugs
Why it was recalled
There is potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Alvogen, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.